COMPASS THERAPEUTICS INC's ticker is CMPX and the CUSIP is 20454B104. A total of 56 filers reported holding COMPASS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,415,500 | -61.4% | 1,226,142 | -37.7% | 1.01% | -32.5% |
Q2 2023 | $6,262,361 | -12.0% | 1,969,296 | -9.5% | 1.50% | -23.9% |
Q1 2023 | $7,118,927 | -36.5% | 2,177,042 | -2.4% | 1.96% | -59.3% |
Q4 2022 | $11,219,000 | +300.0% | 2,230,441 | +81.3% | 4.83% | +364.3% |
Q3 2022 | $2,805,000 | -14.0% | 1,230,441 | 0.0% | 1.04% | -12.4% |
Q2 2022 | $3,261,000 | +87.4% | 1,230,441 | -3.1% | 1.19% | +135.5% |
Q1 2022 | $1,740,000 | -72.6% | 1,270,211 | -36.5% | 0.50% | -67.8% |
Q4 2021 | $6,340,000 | – | 2,000,000 | – | 1.57% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 914,630 | $2,908,523 | 3.52% |
Foresite Capital Management V, LLC | 1,324,071 | $4,210,546 | 3.08% |
CHI Advisors LLC | 2,829,712 | $8,998,484 | 2.73% |
Monashee Investment Management LLC | 1,969,296 | $6,262,361 | 1.50% |
Orbimed Advisors | 22,362,850 | $71,113,863 | 1.29% |
Prosight Management, LP | 2,167,994 | $6,894,220 | 1.03% |
Vivo Capital, LLC | 3,556,023 | $11,308,153 | 0.78% |
BRAIDWELL LP | 5,954,273 | $18,934,588 | 0.62% |
Rock Springs Capital Management LP | 5,513,788 | $17,533,846 | 0.42% |
CAXTON CORP | 43,466 | $138,220 | 0.40% |